OncoC4 is a pioneering biotechnology company focused on developing innovative therapies for challenging cancers. Utilizing unique mechanisms such as CTLA-4, CD24, and siglecs, OncoC4 aims to create first-in-class and best-in-class treatments that improve patient outcomes in oncology.
New York, • United States
California, • United States
California, • United States
New Jersey, • United States
Greater London, • United Kingdom
California, • United States
New York, • United States
Basel-City, • Switzerland
Massachusetts, • United States